Copyright: © 2020 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Impact of р53 modulation on interactions between р53 family members during НаСаT keratinocytes differentiation

About authors

1 Orekhovich Institute of Biomedical Chemistry, Moscow, Russia

2 RMA “Perspektiva”, Novosibirsk, Russia

Correspondence should be addressed: Alexander L. Rusanov
Pogodinskaya 10, bld. 8, Moscow, 119121; moc.liamg@vonasur.l.rednaxela

About paper

Funding: the study involving p53 gene knockdown, ELISA and PCR tests was performed as part of the Fundamental Scientific Research Programs of the State Academies of Sciences for 2013–2020; experiments with Nutlin-3a were carried out by RMA “Perspektiva” and supported by RFBR, project № 18-44-540031/19.

Author contribution: Luzgina NG, Rusanov AL — study concept; Romashin DD, Kozhin PM, Luzgina NG, Rusanov AL — study design and literature analysis; Romashin DD, Kozhin PM, Karagyaur MN — study planning and execution; Kozhin PM, Romashin DD, Luzgina NG, Rusanov AL — data analysis and interpretation; Kozhin PM, Romashin DD — manuscript writing; Kozhin PM, Romashin DD, Karagyaur MN, Luzgina NG, Rusanov AL — manuscript editing, preparation of the final version of the article.

Compliance with ethical standards: the study was carried out in accordance with the World Medical Association Declaration of Helsinki.

Received: 2020-11-27 Accepted: 2020-12-14 Published online: 2020-12-26
|
  1. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The ΔNp63α phosphoprotein binds the P21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay–Wells syndrome-derived mutations. Mol Cell Biol. 2003; 23 (7): 2264–76.
  2. Botchkarev VA, Flores ER. P53/P63/P73 in the epidermis in health and disease. Cold Spring Harb Perspect Med. 2014; 4 (8): a015248.
  3. Koster MI, Roop DR. Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol. 2007; 23 (1): 93–113.
  4. Martynova E, Pozzi S, Basile V, Dolfini D, Zambelli F, Imbriano C, et al. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget. 2012 Feb; 3 (2): 132–43.
  5. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and P53 in the onset of skin cancer. Nature. 1994; 372 (6508): 773–6.
  6. Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A. Switch from P53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene. 2000; 19 (33): 3693–705.
  7. Freije A, Molinuevo R, Ceballos L, Cagigas M, Alonso-Lecue P, Rodriguez R, et al. Inactivation of P53 in human keratinocytes leads to squamous differentiation and shedding via replication stress and mitotic slippage. Cell Rep. 2014; 9 (4): 1349–60.
  8. Seo E-Y, Piao Y-J, Kim J-S, Suhr K-B, Park J-K, Lee J-H. Identification of calcium-induced genes in HaCaT keratinocytes by polymerase chain reaction-based subtractive hybridization. Arch Dermatol Res. 2002; 294 (9): 411–18.
  9. Petushkova NA, Rusanov AL, Pyatnitskiy MA, Larina OV, et al. Proteomic characterization of HaCaT keratinocytes provides new insights into changes associated with SDS exposure. Biomed Dermatol. 2020; 4 (1): 4.
  10. Rusanov AL, Nakhod KV, Nakhod VI, Poverennaya EV, Petushkova NA, Luzgina NG. Changes in the proteome of HaCaT keratinocytes induced by cytotoxic substance Triton X-100. Bull Exp Biol Med. 2017; 163 (5): 620–2.
  11. Smits J, Niehues H, Rikken G, van Vlijmen-Willems I, van de Zande G, Zeeuwen P, et al. Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models. Sci Rep. 2017; 7 (1): pii: 11838.
  12. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis. 1993; 14: 833–9.
  13. Jung Y-S, Qian Y, Yan W, Chen X. Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through P63. J Invest Dermatol. 2013; 133 (5): 1178–87.
  14. Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol. 2011; 223: 116–26.
  15. Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol. 2011; 192: 209–18.
  16. Longo PA, Kavran JM, Kim M-S, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 2013; 529: 227–40.
  17. Riss TL, Moravec RA, Niles AL, Duellman S, et al. Cell viability assays. In Assay Guidance Manual; Sittampalam GS, Grossman A, Brimacombe K, Arkin M, et al, Eds.; Eli Lilly & Company and the National Center for Advancing Translational Sciences: Bethesda (MD), 2004.
  18. McQuin C, Goodman A, Chernyshev V, Kamentsky L, et al. CellProfiler 3.0: Next-generation image processing for biology. PLOS Biol. 2018; 16 (7): e2005970. Available at: https://doi. org/10.1371/journal.pbio.2005970.
  19. R Core Team. R: A language and environment for statistical computing; R foundation for statistical computing: Vienna, Austria. 2013.
  20. Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF. Involucrin — structure and role in envelope assembly. J Invest Dermatol. 1993; 100 (5): 613–7.
  21. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991; 5 (15): 3071–7.
  22. Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J Cell Biol. 2008; 180 (3): 451–8.
  23. Dlugosz AA, Yuspa SH. Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol. 1993; 120 (1): 217–25.
  24. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 1994; 63: 345–82.
  25. Mogulevtseva YuA, Mezentsev AV, Bruskin SA. RNA interference targeting interstitial collagenase is a potential therapeutic tool to treat psoriasis. Bulletin of RSMU. 2017; (3): 35–42.
  26. Xu J, Reumers J, Couceiro JR, De Smet F, Gallardo R, Rudyak S, et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol. 2011; 7: 285–95.
  27. Galli F, Rossi M, D'Alessandra Y, De Simone M, Lopardo T, Haupt Y, et al. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J Cell Sci. 2010; 123 (14): 2423–33.